Direct answer (40-60 words)
If a GLP-1 medication is exposed to room temperature (59 to 86°F) for the labeled in-use window, it stays potent. Above 86°F, the peptide can denature and lose effectiveness. Brand pens are stable at room temperature for 28 days (Wegovy, Zepbound) or 56 days (Ozempic) once first used. Discard any pen or vial exposed to heat above 86°F.
Table of contents
- The 30-second answer
- Why GLP-1s are temperature sensitive
- The exact storage rules by product
- What happens chemically when a peptide gets warm
- The 86°F threshold and why it matters
- Visual checks before injecting
- Travel scenarios and how to keep medication cold
- What to do if your pen was left out
- Compounded semaglutide and tirzepatide stability
- FAQ
- Footer disclaimers
Why GLP-1s are temperature sensitive
GLP-1 receptor agonists are peptide drugs. Semaglutide, tirzepatide, and liraglutide are all chains of amino acids folded into a precise three-dimensional shape. That shape is what binds the receptor. Heat unfolds the chain in a process called denaturation, and once the molecule loses its shape, it loses its ability to act as a GLP-1 agonist.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →This is different from how small-molecule drugs behave. A tablet of metformin can sit in a hot car for a week and still work. A peptide injectable cannot. The bond angles that hold the molecule in its active conformation are weak, so they break with heat the way an egg white turns from clear to opaque on a hot pan.
Manufacturers store these medications cold for two reasons. First, refrigeration slows degradation reactions. A peptide degrades roughly twice as fast for every 10°C rise in temperature, per Arrhenius kinetics. Second, the preservative system in the pen or vial is designed for refrigerated storage. Once the medication warms, the preservative effectiveness drops and bacterial contamination risk rises.
The result is a narrow window of temperatures where GLP-1 medication is both potent and safe. Outside that window, you can't trust the dose.
The exact storage rules by product
The labeling for each branded GLP-1 sets out specific storage parameters. Here is a side-by-side reference based on the FDA-approved prescribing information.
| Product | Refrigerated storage (unopened) | Room-temperature in-use window | Maximum temperature |
|---|---|---|---|
| Ozempic (semaglutide) | 36 to 46°F (2 to 8°C) | Up to 56 days at 59 to 86°F | 86°F (30°C) |
| Wegovy (semaglutide) | 36 to 46°F (2 to 8°C) | Up to 28 days at 59 to 86°F | 86°F (30°C) |
| Zepbound (tirzepatide) | 36 to 46°F (2 to 8°C) | Up to 21 days at up to 86°F | 86°F (30°C) |
| Mounjaro (tirzepatide) | 36 to 46°F (2 to 8°C) | Up to 21 days at up to 86°F | 86°F (30°C) |
| Rybelsus (oral semaglutide) | Room temperature in original blister | Not refrigerated | 86°F (30°C) |
| Saxenda (liraglutide) | 36 to 46°F (2 to 8°C) | Up to 30 days at 59 to 86°F | 86°F (30°C) |
A few details that get lost in the shuffle:
- The in-use window starts the day you inject the first dose. Mark that date on the pen with a marker.
- Refrigeration after first use is allowed for all of these products. It doesn't extend the in-use window past the labeled day count, but it can extend potency if you've had a stretch where the pen sat at the upper end of the room-temperature range.
- Freezing destroys these medications. If a pen has been below 36°F at any point, even briefly, the peptide can crystallize and the cartridge integrity is compromised. Discard it.
What happens chemically when a peptide gets warm
Three things can happen to a GLP-1 peptide when it warms past the labeled threshold.
Denaturation. The folded structure that holds the active site relaxes. The molecule still exists, but it can't bind the GLP-1 receptor anymore. You can't see denaturation. The liquid looks the same. The pen still clicks the same. The injection still feels the same. The dose just doesn't work.
Aggregation. Once unfolded, peptide chains can stick to each other and form clumps. Aggregated peptide is visible as cloudiness or fine particulate in the cartridge. Aggregates are also a known immunogenicity risk, meaning they can trigger antibody formation that reduces drug effectiveness over time and rarely causes injection-site reactions.
Hydrolysis. Water molecules in the cartridge slowly break peptide bonds at warmer temperatures. This is irreversible. The peptide chain shortens, and the fragments are inactive. Manufacturers calibrate the in-use window to keep hydrolysis below the threshold where potency drops more than 5%.
A peptide can fail any one of these tests and still look fine in the cartridge. That's why time and temperature, not visual inspection alone, are the primary safety checks.
The 86°F threshold and why it matters
The 86°F (30°C) ceiling shows up in every GLP-1 label for a reason. Manufacturer stability testing follows International Council for Harmonisation (ICH) guidelines, which specify accelerated stability studies at 25°C and 30°C. Above 30°C, the degradation rate accelerates beyond what the in-use window assumes.
A few real-world scenarios that cross 86°F:
- A car parked in direct sun, even on a 75°F day, can hit 110°F+ inside within 30 minutes.
- A checked airline bag in a hot tarmac hold can exceed 100°F.
- A mailbox in summer afternoon sun frequently passes 90°F.
- A windowsill in a kitchen during cooking can spike past 86°F.
- A purse left near a heated car vent or in a beach bag is a common offender.
If your medication has been in any of these for more than 30 minutes, treat it as exposed. The exact damage threshold isn't published per minute of exposure, but the conservative assumption is that an hour at 95°F or more is enough to see measurable potency loss in semaglutide and tirzepatide.
Visual checks before injecting
Before any injection, look at the cartridge or vial for these signs:
| Visual sign | What it means | Action |
|---|---|---|
| Clear, colorless solution | Normal | Proceed |
| Slight haziness when first removed from fridge | Condensation, normal | Let warm 15 minutes, recheck |
| Persistent cloudiness or milkiness | Possible aggregation | Do not use |
| Visible particles or flecks | Aggregation or contamination | Do not use |
| Color change (yellow, brown) | Oxidation or degradation | Do not use |
| Frozen or ice crystals | Cold damage | Do not use, even after thawing |
The hardest case is the pen that looks fine but was definitely exposed to heat. There is no home test that confirms potency. The conservative answer is to discard. The pragmatic answer some patients choose is to inject and watch closely for the next dose to see if appetite suppression and side effects feel typical. We don't recommend the pragmatic approach, because heat-damaged peptide can also drive immunogenicity that won't show up for weeks.
Travel scenarios and how to keep medication cold
Most heat exposures happen during travel. A few practical setups, by trip length:
Day trips (under 4 hours). A small insulated lunch bag with a frozen gel pack is enough. Keep the pen in a sealed plastic bag inside the lunch bag so condensation doesn't pool around the cartridge. Avoid direct contact between the pen and the gel pack. Wrap the gel pack in a thin towel.
Air travel (4 to 24 hours). Carry-on only. TSA allows medically necessary liquids and injectable medications without quantity limits. Put the pen in an insulated travel case with a fresh gel pack at security and ask TSA for a hand-inspection if needed. Do not check medication. The cargo hold can drop below freezing on long flights and spike above 100°F on hot tarmacs.
International or multi-day travel. Use a Frio cooling wallet (evaporative, doesn't need a freezer) or a portable medical refrigerator. If you have refrigerator access at the destination, transfer the pen to the fridge on arrival. Keep one ice pack frozen in the destination freezer to recharge the travel cooler for the return.
Camping or off-grid trips. A 12V powered cooler that runs off a car battery is the most reliable solution. Battery-powered insulin coolers (Frio, MedAngel, BluDrop) have 4 to 8 hour cooling capacity per charge. Plan accordingly.
A single insulated cooler bag with a gel pack typically holds the medication below 50°F for 6 to 8 hours. Past that, the gel pack thaws and the bag warms toward ambient temperature.
What to do if your pen was left out
This is the question patients call us with most often. Here is the decision tree.
Step 1: How long was it out? If under 24 hours total at typical room temperature (under 86°F), and the in-use room-temperature window for the product hasn't expired, the pen is still usable. Wegovy gets 28 days, Ozempic gets 56 days, Zepbound and Mounjaro get 21 days from first use.
Step 2: How hot did it get? If it stayed below 86°F the entire time, the labeled in-use window applies. If it exceeded 86°F at any point you can verify (in a car, on a heater, in direct sun), assume the medication is compromised. The conservative answer is to discard.
Step 3: Was it frozen? Any freezing is disqualifying. Visual inspection won't always show ice crystals because the fluid can refreeze invisibly. If you're unsure whether it froze, err on the side of discard.
Step 4: Visual inspection. Cloudiness, particles, or color change means discard regardless of time and temperature history.
Step 5: When in doubt, call the pharmacy. Most major pharmacies will not replace a pen for free if you left it out, but they can walk you through the manufacturer's specific guidance for borderline cases. Manufacturers (Novo Nordisk, Eli Lilly) also have customer support lines that handle these questions.
Compounded semaglutide and tirzepatide stability
Compounded GLP-1 medications come from licensed compounding pharmacies and have storage rules set by the pharmacy, not by an FDA label. Most compounding pharmacies follow the same general principles as the brand-name products, but there are some important differences.
Refrigeration is the default. Compounded semaglutide and tirzepatide are typically prepared as multi-dose vials and shipped on ice. Refrigerate immediately on receipt at 36 to 46°F.
In-use windows vary. A compounded vial may have a beyond-use date (BUD) of 28 to 90 days from preparation, depending on the formulation, preservative, and the pharmacy's USP 797 stability testing. The pharmacy label should tell you the BUD.
Room-temperature stability is usually shorter. Most compounded GLP-1 vials are not validated for extended room-temperature storage. Treat them as refrigerated medications and minimize time at room temperature. A 30-minute warm-up before injection is fine. Multiple days at room temperature is not.
Multi-dose vials add a contamination risk. Each needle entry into a compounded vial introduces potential bacterial exposure. The preservative in the vial is calibrated for refrigerated storage. Warm storage shortens the safe in-use window because preservative effectiveness drops at higher temperatures.
If you're unsure about your compounded vial, contact the dispensing pharmacy directly. Reputable compounding pharmacies can confirm BUD, ideal storage, and what to do if a vial was exposed to heat. (See our compounded semaglutide reconstitution guide for related dosing references.)
FAQ
What temperature is too warm for a GLP-1 pen?
Anything above 86°F (30°C). Brief excursions of a few minutes during transport from fridge to injection are fine. Sustained exposure of 30 minutes or more above 86°F is the threshold where potency loss becomes a real concern.
Can I still use my Ozempic if it sat at room temperature overnight?
If room temperature stayed below 86°F and you're within the 56-day in-use window for Ozempic from first use, yes. If the pen exceeded 86°F or has been in use more than 56 days, discard.
Can I still use my Wegovy if it sat at room temperature overnight?
If under 86°F and within the 28-day in-use window from first use, yes. Beyond 28 days or above 86°F, discard.
What about Zepbound at room temperature?
Zepbound is stable at room temperature up to 86°F for 21 days from first use. Past that or above that temperature, discard.
Will a warm GLP-1 hurt me if I inject it?
The peptide itself becoming inactive is the main risk, meaning the dose may not work. Aggregated peptide can rarely cause injection-site reactions or trigger antibody formation. Bacterial contamination from preservative breakdown is also possible at high temperatures. The most likely outcome of injecting a heat-exposed dose is no clinical effect, not acute harm, but the longer-term immunogenicity risk is real.
How can I tell if my GLP-1 has gone bad?
Look for cloudiness, particles, color change, or anything that wasn't there before. A clear, colorless solution that has been temperature-controlled is presumed good. A pen that looks fine but had a confirmed heat exposure should still be discarded, because visual inspection doesn't catch denaturation.
Is freezing or heat worse for GLP-1 medication?
Both are disqualifying. Freezing causes irreversible peptide aggregation and cartridge integrity loss. Heat causes denaturation and accelerated degradation. There is no middle ground that recovers the medication after either exposure.
Can I refrigerate my GLP-1 pen between doses if I prefer?
Yes. All major brand pens allow refrigeration during the in-use window. Refrigeration does not extend the labeled day count, but it slows degradation if your room temperature trends warm.
How do I store a GLP-1 pen during a power outage?
Keep the refrigerator door closed. Most refrigerators hold below 50°F for 4 to 6 hours unopened. For longer outages, transfer the pen to a cooler with ice packs. If the medication exceeded 86°F at any point, treat it as exposed.
What if my pharmacy shipped my GLP-1 in summer heat?
Most reputable mail-order pharmacies ship overnight in insulated packaging with ice packs. On arrival, check the ice pack. If the pack is still partially frozen, the medication was almost certainly kept cold enough. If the package arrived warm with fully thawed packs, contact the pharmacy. Most will reship at no charge for confirmed heat exposure.
Do GLP-1 patches or oral forms have different storage rules?
Rybelsus (oral semaglutide) is the only oral GLP-1 currently FDA-approved and is stored at room temperature in its original blister pack. Topical or patch GLP-1 forms are not FDA-approved.
Does altitude affect GLP-1 stability?
No, but air pressure changes during flight can stress sealed cartridges. The TSA-friendly approach is to keep medication in pressurized cabin baggage rather than the cargo hold, where pressure and temperature both swing.
Can I leave my GLP-1 in the bathroom medicine cabinet?
Bathroom temperatures fluctuate widely with shower humidity and ambient swings. A bedroom or kitchen storage location away from heat sources is safer. The original packaging is opaque, which protects from light, so don't store the pen unboxed.
Author / review note
Reviewed by the FormBlends Medical Team. References include the Ozempic, Wegovy, Zepbound, and Mounjaro FDA-approved prescribing information (latest revisions), USP General Chapter 797 (Pharmaceutical Compounding, Sterile Preparations), International Council for Harmonisation Q1A(R2) Stability Testing of New Drug Substances and Products, and Novo Nordisk and Eli Lilly published storage data.
Footer disclaimers (all 4 verbatim)
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Saxenda is a registered trademark of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →